By acquiring remedix, we have added narcotics to our range of EU pharmaceuticals, allowing us to offer a comprehensive portfolio from a single source. Since 2016, remedix has been part of the axicorp Group and markets innovative EU narcotics in Germany from multinational original manufacturers. This enables us to supply patent-protected original pharmaceuticals more cheaply as parallel imports, and re imports, thus creating savings in the healthcare system.
Unlike copycat preparations (generics), EU narcotics are original products from re search-based pharmaceutical manufacturers whose medicines are often still under patent protection. This means that remedix products are researched and innovative branded medicines. In Germany, narcotics are monitored by the Federal Narcotics Control Board (Bundesopiumstelle) within the Federal Institute for Drugs and Medical Devices (BfArM).
axicorp’s centrally located company headquarters in Friedrichsdorf and its modern narcotics warehouse are optimally positioned to ensure efficient logistics and fast, reliable delivery. By working in partnership with certified EU suppliers and pharmaceutical wholesalers, we guarantee secure and standardised processes as well as high service quality.
remedix is also a partner for medical cannabis and a specialized trader. The diverse therapeutic spectrum of medical cannabis leads to an increased demand from our customers.